Proteomics

Dataset Information

0

Oleuropein reprograms the immunosuppressive footprint of tumor-associated myeloid cells and enhances PD-L1/PD-1 blockade immunotherapy in cancer


ABSTRACT: Therapies based on PD-1/PD-L1 blockade fail in most cancer patients. Here we evaluated the capacities of oleuropein to reprogram tumor-associated immunosuppressive myeloid cells to increase the potency of immunotherapies. Oleuropein caused major global reprogramming of monocytic and granulocytic myeloid-derived suppressor cells and tumor-associated macrophages towards immunostimulatory subsets. Differential quantitative proteomics uncovered activated and down-modulated pathways at high resolution for each subset which regulated major differentiation programs. Oleuropein significantly potentiated the capacities of myeloid cells to activate T-cells and enhanced antitumor properties of PD-1 blockade, either by systemic anti-PD-1 antibody administration, or locally by intratumor antibody delivery with a self-amplifying RNA vector based on Semliki Forest virus. Combination therapies decreased tumor infiltration by immunosuppressive myeloid cells and increased dendritic cell recruitment within draining lymph nodes, leading to systemic antitumor T-cell responses. Potent therapeutic activities were evident in lung cancer models resistant to immunotherapies and in colon cancer models.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: David Escors 

PROVIDER: PXD047616 | JPOST Repository | Sun Dec 08 00:00:00 GMT 2024

REPOSITORIES: jPOST

Dataset's files

Source:
Action DRS
GM_C01.raw Raw
GM_C02.raw Raw
GM_C03.raw Raw
GM_C04.raw Raw
GM_C05.raw Raw
Items per page:
1 - 5 of 20

Similar Datasets

2022-10-19 | GSE210334 | GEO
2022-10-17 | GSE211388 | GEO
2019-01-16 | GSE122969 | GEO
2024-03-04 | GSE260598 | GEO
2024-03-04 | GSE260597 | GEO
2024-03-04 | GSE260596 | GEO
2021-10-12 | GSE178245 | GEO
2012-07-09 | E-GEOD-39205 | biostudies-arrayexpress
2021-10-18 | GSE154795 | GEO
2024-07-01 | GSE267814 | GEO